HLA-DR expression at diagnosis is not predictive of relapse risk post allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

Creator(s)

• Vasant Chinnabhandar
• Michael R. Verneris
• Kirk R. Schultz
• Alan S. Gamis, Children's Mercy HospitalFollow
• Richard Aplenc
• Chad A. Hudson
• Todd A. Alonzo
• Robert B. Gerbing
• John T. Horan
• Joseph H. Chewning

Document Type

Letter to the Editor

Publication Date

9-1-2026

Identifier

DOI: 10.3324/haematol.2025.288751; PMCID: PMC13530937

Journal Title

Haematologica

Volume

111

Issue

9

First Page

3093

Last Page

3096

PubMed ID

41885017

Comments

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Publisher's Link: https://haematologica.org/article/view/13415

Recommended Citation

Chinnabhandar V, Verneris MR, Schultz KR, et al. HLA-DR expression at diagnosis is not predictive of relapse risk post allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Haematologica. 2026;111(9):3093-3096. doi:10.3324/haematol.2025.288751